FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
The U.S. Food and Drug Administration cleared the first blood test, which measures two key biomarkers, to aid in diagnosing Alzheimer’s disease in people exhibiting symptoms of the disease.
The U.S. Food and Drug Administration cleared the first blood test, which measures two key biomarkers, to aid in diagnosing Alzheimer’s disease in people exhibiting symptoms of the disease.
